S
Skye Bioscience, Inc. (SKYE)
NGM – Real vaqt narxi. Valyuta: USD
0.81
-0.07 (-7.56%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
0.81
-0.07 (-7.56%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Skye Bioscience, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, semizlik, ortiqcha vazn va metabolik kasalliklarni davolash uchun G-protein bilan bog'langan retseptorlarni (GPCR) modulyatsiya qiluvchi molekulalarni ishlab chiqishga qaratilgan. Uning asosiy mahsulot nomzodi - nimacimab, periferik cheklangan salbiy allosterik modulyatsiya qiluvchi antiteladir, u metabolik regulyatsiyada ishtirok etadigan asosiy GPCR bo'lgan kannabinoid retseptor 1 ga qaratilgan. Kompaniya ilgari Emerald Bioscience, Inc. nomi bilan tanilgan va 2021-yil yanvar oyida Skye Bioscience, Inc. nomini o'zgartirgan. Skye Bioscience, Inc. Kaliforniyaning San-Diego shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Christopher G. Twitty Ph.D. | Chief Scientific Officer |
| Dr. Puneet S. Arora FACE, M.D., M.S. | Chief Medical Officer |
| Mr. John P. Sharp CPA | CFO and Principal Financial & Accounting Officer |
| Mr. Punit S. Dhillon B.A. | President, CEO & Director |
| Mr. Tu Diep M.Sc. | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-11 | 10-Q | skye-20260331.htm |
| 2026-04-16 | DEFA14A | skye20260416-proxycarddefa.htm |
| 2026-04-16 | DEF 14A | skye-20260415.htm |
| 2026-04-06 | PREM14A | skye_20260403xproxyxprelim.htm |
| 2026-04-06 | PRE 14A | skye_20260406xproxyxprelim.htm |
| 2026-04-06 | 8-K/A | skye-20260331.htm |
| 2026-04-03 | 8-K | skye-20260331.htm |
| 2026-03-19 | 8-K | skye-20260317.htm |
| 2026-03-11 | S-8 | skye-03102026_sx8evergreen.htm |
| 2026-03-10 | 8-K | skye-20260310.htm |